Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025 by Seini Moimoi | Apr 28, 2025 | Portfolio News
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting by Seini Moimoi | Apr 26, 2025 | Portfolio News
ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 by Seini Moimoi | Apr 24, 2025 | Portfolio News
Endeavor BioMedicines Appoints Internationally Renowned ILD Expert Lisa Lancaster, M.D., as Chief Medical Officer by Seini Moimoi | Apr 2, 2025 | Portfolio News
Cohere Health Launches Cohere Align to Move Beyond Gold Carding with Smarter Prior Authorization for Health Plans by Seini Moimoi | Mar 25, 2025 | Portfolio News
